 BTIG Research reaffirmed their buy rating on shares of Misonix NASDAQ:MSON in a research note issued to investors on Tuesday morning, AnalystRatings.com reports. The firm currently has a 18.00 target price on the medical equipment providers stock. A number of other brokerages have also weighed in on MSON. Craig Hallum raised their target price on ... 